Stock Market Today: All You Need To Know Going Into Trade On May 4

[view original post]

Hero MotoCorp Q4 FY22 (Standalone, YoY)

  • Revenue fell 15% to Rs 7,421 crore (BBG estimate: Rs 7,465 crore)

  • Net profit fell 28% to Rs 627 crore (BBG estimate: Rs 625 crore)

  • Ebitda down 32% at Rs 828 crore (BBG estimate: Rs 877 crore)

  • Margin at 11.2 % vs 13.90% (BBG estimate: 11.75%)

Adani Wilmar Q4 FY22 (Consolidated, YoY)

  • Revenue up 40% at Rs 14,960.37 crore

  • Net profit fell 26% to Rs 234.3 crore

  • EBITDA rose 21% to Rs 425.72 crore

  • Margins at 2.8% versus 3.3%

Jindal Stainless Q4 FY22 (Consolidated, YoY)

  • Revenue up 68% at Rs 6,563.51 crore Vs Rs 3,913.64 crore

  • EBITDA up 55.2% at Rs 841.59 crore Vs Rs 542.22 crore

  • EBITDA margin 12.82% Vs 13.85%

  • Net profit up 154% at Rs 735.53 crore Vs Rs 289.19 crore

  • Approved transfer of entire stake in JSL Ferrous, wholly owned subsidiary of the company to Jindal United Steel, associate company.

Castrol India Q4 FY22 (Consolidated, YoY)

  • Revenue up 8.5% at Rs 1,235.7 crore Vs Rs 1,138.7 crore

  • EBITDA fell 6.7% at Rs 317.20 crore Vs Rs 340.1 crore

  • EBITDA margin 25.67% Vs 29.87%

  • Net profit fell 6.2% at Rs 228.4 crore Vs Rs 243.6 crore

Britannia Industries Q4 FY22

  • Revenue up 13% at Rs 3,550.45 crore Vs Rs 3,130.75 crore (Bloomberg Estimate: Rs 3,457.8 crore)

  • Net profit up 4% to Rs 379.87 crore from Rs 364.32 crore (Bloomberg Estimate: Rs 378.76 crore)

  • EBITDA up 8.7 % to Rs 549.68 crore Vs Rs 505.39 crore (Bloomberg Estimate: Rs 526.51)

  • Margins at 15.5% Vs 16.1% (Bloomberg Estimate: 15.2%)

M&M Financial Services Q4 FY22 (Consolidated, YoY)

  • Revenue fell 4.8% at Rs 2,865.08 crore Vs Rs 3,007.26 crore

  • EBIT up 31% at Rs 1,882.42 crore Vs Rs 1,436.57 crore

  • EBIT margin 65.7% Vs 47.77%

  • Net profit up 188% at Rs 623.78 crore Vs Rs 216.34 crore

  • Recommended dividend of Rs 3.6 per share of face value of Rs 2 each

JBM Auto Q4 FY22 (Consolidated, YoY)

  • Revenue up 44% at Rs 1072.29 crore Vs Rs 744.88 crore

  • EBITDA up 46% at Rs 123.05 crore Vs Rs 84.18 crore

  • EBITDA margin 11.48% Vs 11.3%

  • Net profit up 165% at Rs 85.63 crore Vs Rs 32.24 crore

  • Recommended final dividend of Rs 1 per share on face value of Rs 2 each

Alembic Pharmaceuticals Q4 FY22 (Consolidated, YoY)

  • Revenue up 9% at Rs 1,426 crore Vs Rs 1,306 crore (Bloomberg Estimate: Rs 1,254 crore)

  • EBITDA down 51% to Rs 170 crore from Rs 346 crore (Bloomberg Estimate: Rs 243 crore)

  • Margins at 11.9% Vs 26.5% (Bloomberg Estimate: 19.3%)

  • Net profit down 86% at Rs 34 crore from Rs 251 crore (Bloomberg Estimate: Rs 154 crore)

  • EPS at Rs 1.8 per share vs Rs 12.75 per share (Bloomberg Estimate: Rs 7.3)